A myasthenia gravis treatment revolution has taken place in the past four years, spurred by an initial approval for argenx’s ...
A wrist-worn, AI-driven transcutaneous peripheral nerve stimulator is linked to greater improvement in patients with ...
Physical therapy is routinely recommended for knee pain attributed to a degenerative meniscal tear, but its efficacy has not ...
To get a more complete account of what took place, The Cavalier Daily reviewed court transcripts and other documents in ...
VYVGART demonstrated clinically meaningful benefit across all AChR-Ab seronegative gMG subtypes in ADAPT SERON, supporting broad role of ...
Ironically, while the JFN claims that CIJA is attempting to silence “Palestinians, their allies and supporters, including ...
When treatment for Alzheimer's disease, one of the most common brain disorders worldwide and in India, is discussed, conversations usually revolve around memory loss and medication. But according to ...
1. About lecanemab (generic name, brand name: LEQEMBI®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...
AI-driven nerve stimulation shows significant improvement in essential tremor symptoms, offering a noninvasive treatment ...
Researchers worry that Medicaid home care eligibility decisions are often made without public scrutiny and based less on ...
Dongfeng Gu and colleagues review community based cohort studies in China, finding strategies to improve the quality and scale of these studies in China and beyond Community based cohort studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback